GeoVax Labs (Nasdaq: GOVX) 10,000-participant randomized Phase 2b study will evaluate and compare GeoVax’s multi-antigen,...
Virax Biolabs Group (NASDAQ: VRAX) experienced a notable increase in its stock value today due...
Top Small Cap Stocks
GeoVax Labs (Nasdaq: GOVX) 10,000-participant randomized Phase 2b study will evaluate and compare GeoVax’s multi-antigen,...
Virax Biolabs Group (NASDAQ: VRAX) experienced a notable increase in its stock value today due...